(Q43721711)

26 November 2017

title

Severe erectile dysfunction is a marker for hyperprolactinemia (English)

1 reference

26 November 2017

1 reference

Johri AM

1

1 reference

26 November 2017

Heaton JP

series ordinal

2

1 reference

26 November 2017

Morales A

series ordinal

3

1 reference

26 November 2017

publication date

1 June 2001

1 reference

International Journal of Impotence Research

26 November 2017

published in

1 reference

26 November 2017

volume

13

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

176-182

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3900675

26 November 2017

exact match

0 references

cites work

Routine prolactin measurement is not necessary in the initial evaluation of male impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Endocrine dysfunction in impotence: incidence, significance and cost-effective screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Erectile dysfunction--the paradigm changes but the challenges remain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Is management of impotence with sildenafil changing clinical practice?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Diagnostic and treatment strategies for erectile dysfunction: the 'Process of Care' model. [University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Is routine endocrine testing of impotent men necessary?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Role of serum prolactin determination in evaluation of impotent patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Characterization of big, big prolactin in patients with hyperprolactinaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Asymptomatic 'big' hyperprolactinemia in two men with pituitary adenomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Routine endocrine screening in impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Hyperprolactinemia and impotence: why, when and how to investigate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Prolactin-Secreting Tumors and Hypogonadism in 22 Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Oral sildenafil in erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900675

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900675

1 reference

Dimensions Publication ID

26 November 2017

1007714013

0 references

1 reference